Cross Country Healthcare, Inc.
CCRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $250 | $274 | $293 | $310 |
| % Growth | -8.8% | -6.6% | -5.3% | – |
| Cost of Goods Sold | $199 | $218 | $235 | $248 |
| Gross Profit | $51 | $56 | $59 | $62 |
| % Margin | 20.4% | 20.4% | 20% | 20% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $47 |
| SG&A Expenses | $0 | $50 | $52 | $55 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $9 |
| Other Operating Expenses | $57 | $12 | $7 | $10 |
| Operating Expenses | $57 | $62 | $60 | $65 |
| Operating Income | -$6 | -$6 | -$1 | -$3 |
| % Margin | -2.4% | -2.1% | -0.3% | -1.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$6 | -$6 | -$1 | -$4 |
| Tax Expense | -$1 | $1 | -$0 | -$0 |
| Net Income | -$5 | -$7 | -$0 | -$4 |
| % Margin | -1.9% | -2.4% | -0.2% | -1.2% |
| EPS | -0.15 | -0.2 | -0.02 | -0.12 |
| % Growth | 25% | -900% | 83.3% | – |
| EPS Diluted | -0.15 | -0.2 | -0.02 | -0.12 |
| Weighted Avg Shares Out | 33 | 32 | 32 | 32 |
| Weighted Avg Shares Out Dil | 33 | 32 | 32 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $4 | $4 | $5 | $4 |
| EBITDA | -$1 | -$1 | $4 | $4 |
| % Margin | -0.4% | -0.4% | 1.5% | 1.3% |